Amphastar Pharmaceuticals (AMPH) Buildings (2013 - 2015)

Amphastar Pharmaceuticals has reported Buildings for 3 years, with the latest figure at $67.8 million in Q2 2015.

• On a quarterly basis, Buildings rose 5.71% year-over-year to $67.8 million in Q2 2015; TTM through Jun 2015 was $67.8 million, a 5.71% increase from a year earlier, with the FY2014 full-year figure at $67.8 million, up 15.05% from the prior year.
• Buildings was $67.8 million for Q2 2015 at Amphastar Pharmaceuticals, up from $67.4 million in the prior quarter.
• The five-year high for Buildings was $67.8 million in Q2 2015, with the low at $58.9 million in Q4 2013.
• Average Buildings over 3 years is $65.5 million, with a median of $67.1 million recorded in 2014.
• The sharpest annual moves came in 2014 and 2015: Buildings rose 15.05% in 2014, then increased 5.71% in 2015.
• Over 3 years, Buildings stood at $58.9 million in 2013, then advanced by 15.05% to $67.8 million in 2014, then rose by 0.09% to $67.8 million in 2015.
• The last three Buildings figures came in at $67.8 million (Q2 2015), $67.4 million (Q1 2015), and $67.8 million (Q4 2014), per Business Quant data.